BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 30478715)

  • 1. Innovative Therapies for Cystic Fibrosis: The Road from Treatment to Cure.
    Cabrini G
    Mol Diagn Ther; 2019 Apr; 23(2):263-279. PubMed ID: 30478715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis of cystic fibrosis: from bench to bedside.
    Dechecchi MC; Tamanini A; Cabrini G
    Ann Transl Med; 2018 Sep; 6(17):334. PubMed ID: 30306073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repairing mutated proteins--development of small molecules targeting defects in the cystic fibrosis transmembrane conductance regulator.
    Merk D; Schubert-Zsilavecz M
    Expert Opin Drug Discov; 2013 Jun; 8(6):691-708. PubMed ID: 23574506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new era of personalized medicine for cystic fibrosis - at last!
    Quon BS; Wilcox PG
    Can Respir J; 2015; 22(5):257-60. PubMed ID: 26083544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breakthrough therapies: Cystic fibrosis (CF) potentiators and correctors.
    Solomon GM; Marshall SG; Ramsey BW; Rowe SM
    Pediatr Pulmonol; 2015 Oct; 50 Suppl 40(0 40):S3-S13. PubMed ID: 26097168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One Size Does Not Fit All: The Past, Present and Future of Cystic Fibrosis Causal Therapies.
    Ensinck MM; Carlon MS
    Cells; 2022 Jun; 11(12):. PubMed ID: 35740997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of CFTR modulators for the treatment of cystic fibrosis.
    Lopes-Pacheco M; Pedemonte N; Veit G
    Expert Opin Drug Discov; 2021 Aug; 16(8):897-913. PubMed ID: 33823716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome Editing for Cystic Fibrosis.
    Wang G
    Cells; 2023 Jun; 12(12):. PubMed ID: 37371025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translating the genetics of cystic fibrosis to personalized medicine.
    Corvol H; Thompson KE; Tabary O; le Rouzic P; Guillot L
    Transl Res; 2016 Feb; 168():40-49. PubMed ID: 25940043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystic fibrosis transmembrane conductance regulator modulators: precision medicine in cystic fibrosis.
    Burgener EB; Moss RB
    Curr Opin Pediatr; 2018 Jun; 30(3):372-377. PubMed ID: 29538046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for the etiological therapy of cystic fibrosis.
    Maiuri L; Raia V; Kroemer G
    Cell Death Differ; 2017 Nov; 24(11):1825-1844. PubMed ID: 28937684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics of cystic fibrosis treatment.
    Carter SC; McKone EF
    Pharmacogenomics; 2016 Aug; 17(13):1453-63. PubMed ID: 27490265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. F508del-cystic fibrosis transmembrane regulator correctors for treatment of cystic fibrosis: a patent review.
    Yang H; Ma T
    Expert Opin Ther Pat; 2015; 25(9):991-1002. PubMed ID: 25971311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rewriting CFTR to cure cystic fibrosis.
    Maule G; Ensinck M; Bulcaen M; Carlon MS
    Prog Mol Biol Transl Sci; 2021; 182():185-224. PubMed ID: 34175042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New therapies for cystic fibrosis targeting the CFTR gene or the CFTR protein].
    Hubert D; Bui S; Marguet C; Colomb-Jung V; Murris-Espin M; Corvol H; Munck A
    Rev Mal Respir; 2016 Oct; 33(8):658-665. PubMed ID: 26806675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New pharmacological approaches for cystic fibrosis: promises, progress, pitfalls.
    Bell SC; De Boeck K; Amaral MD
    Pharmacol Ther; 2015 Jan; 145():19-34. PubMed ID: 24932877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystic fibrosis: toward personalized therapies.
    Ikpa PT; Bijvelds MJ; de Jonge HR
    Int J Biochem Cell Biol; 2014 Jul; 52():192-200. PubMed ID: 24561283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repairing the basic defect in cystic fibrosis - one approach is not enough.
    Farinha CM; Matos P
    FEBS J; 2016 Jan; 283(2):246-64. PubMed ID: 26416076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New treatments targeting the basic defects in cystic fibrosis.
    Fajac I; Wainwright CE
    Presse Med; 2017 Jun; 46(6 Pt 2):e165-e175. PubMed ID: 28554723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel therapeutic approaches for cystic fibrosis.
    Wilschanski M
    Discov Med; 2013 Feb; 15(81):127-33. PubMed ID: 23449115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.